CLINICAL TRIALS PROFILE FOR TENAPANOR HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for tenapanor hydrochloride
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01764854 ↗ | Pharmacodynamic Study of AZD1722 in End-stage Renal Disease Patients on Hemodialysis | Completed | AstraZeneca | Phase 2 | 2013-01-01 | The purpose of this study is to determine if the study drug is safe, tolerable and active in reducing fluid overload/weight gain between dialysis sessions for patients with End Stage Renal Disease on Hemodialysis. |
NCT01764854 ↗ | Pharmacodynamic Study of AZD1722 in End-stage Renal Disease Patients on Hemodialysis | Completed | Ardelyx | Phase 2 | 2013-01-01 | The purpose of this study is to determine if the study drug is safe, tolerable and active in reducing fluid overload/weight gain between dialysis sessions for patients with End Stage Renal Disease on Hemodialysis. |
NCT02176252 ↗ | Safety, Tolerability, Pharmacokinetics and Pharmacodynamic of AZD1722 in Healthy Male and Female Japanese Subjects | Completed | AstraZeneca | Phase 1 | 2013-07-01 | The study is designed to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of AZD1722 in healthy Japanese subjects at increasing doses given for 7 days in order to allow for including Japanese subjects in future global studies. A cohort of Caucasian subjects will be included in the study to evaluate cardiac effects, assessed by digital ECGs (dECG) recordings, also in Caucasian subjects. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for tenapanor hydrochloride
Condition Name
Clinical Trial Locations for tenapanor hydrochloride
Trials by Country
Clinical Trial Progress for tenapanor hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for tenapanor hydrochloride
Sponsor Name